Atlas Trials

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location

Clinical trial NCT04925583 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04925583
Sponsor
University Hospital Heidelberg
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Cancer
Start date
2021-11-01
Primary completion
2030-11-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.